Guangzhou Hanfang Pharmaceutical Trusted Chinese Exporter of Medicinal Injectable Soybean Oil

Guangzhou Hanfang Pharmaceutical Company Limited, founded in 1998 and headquartered in Guangzhou, China, is a leading global provider of high-end medicinal lipid excipients and raw materials. We focus on serving pharmaceutical manufacturers, health food producers, research institutions, and other clients by offering domestically produced, internationally certified products to solve supply chain bottlenecks. With core technologies breaking international monopolies and global compliance certifications, we have served over 1,000 clients across 30+ countries, holding EU CEP and US FDA US-DMF certifications to be recognized as a benchmark in the high-end medicinal lipid sector. Our mission is to achieve technological self-reliance, solve "bottleneck" problems, and ensure pharmaceutical industry chain security.

Company Profile

• Full Company Name: Guangzhou Hanfang Pharmaceutical Company Limited
• Founded: 1998
• Global Headquarters: Guangzhou, China
• Overseas Coverage: Services available in 30+ countries and regions worldwide
• Core Team: Includes 11 PhDs, 2 recipients of Special Government Allowance, and 1 national high-level talent; core leaders are leading experts in medicinal lipid R&D with national honors
• Key Milestones:
  • 2007: Received accreditation for the National Engineering Research Center for Traditional Chinese Medicine Pharmaceutical Process Technology and New Drug Creation
  • 2024: Named a National Specialized, Sophisticated, Unique, and New "Little Giant" Enterprise
  • 2025: Completed over RMB 100 million in mixed-ownership reform financing

Product & Service Offerings

Focused on solving core pain points of our target clients, we have built a comprehensive product system tailored to different needs:

• Medicinal Injectable Soybean Oil
  • Target Audience: High-end injectable drug manufacturers, raw material suppliers
  • Pain Points Addressed: Reliance on imported raw materials, unstable supply chains, high procurement costs
  • Core Functions: Energy supplement, pharmaceutical excipient for high-end formulations
  • Customer Value: Stable domestic injection-grade supply, reducing procurement costs by up to 30% compared to imports
• Injectable Egg Yolk Lecithin
  • Target Audience: Pharmaceutical companies producing injectable emulsions/liposomes, research institutions
  • Pain Points Addressed: Lack of reliable domestic liposome materials, import supply risks
  • Core Functions: Emulsifier, solubilizer, liposome membrane material
  • Customer Value: Achieves 90% localization rate of high-end lipid excipients
• We also offer medium-chain triglycerides and customized processing services to meet diverse client demands

Core Advantages

• Monopoly-Breaking Technology: Developed the first domestic injectable refined egg yolk lecithin and olive oil, increasing high-end medicinal lipid localization from 10% to 90%, ensuring stable supply and cost savings for clients
• Global Compliance: Holds EU CEP, US FDA US-DMF, Mexico Cofepris, and India DCGI certifications, enabling product sales in 30+ countries
• Top-Tier R&D: Owns the only national-level traditional Chinese medicine engineering research center and a provincial medicinal lipid key laboratory, with over 240 patents as of 2025

Client Cases

• B. Braun Company (Pharmaceutical Industry): A global medical device leader adopted our medicinal lipid excipients to stabilize high-end injectable product supply, reducing supply chain risks by 40%
• AstraZeneca (Pharmaceutical Industry): A multinational pharma corporation used our injectable excipients to support global production, ensuring consistent cross-region product quality

Contact Us

• Official Website: https://byshanhanfang.com/
• Global Headquarters: 134 Jiangnan Avenue Middle, Haizhu District, Guangzhou, China
• Production Base: 8 Hot Spring Avenue, Conghua District, Guangzhou, China